These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2370792)

  • 1. [Indicators of central hemodynamics and myocardial contractility function im myasthenic patients on glucocorticoid treatment].
    Mamikonian AA; Gekht BM; Orlov VA
    Klin Med (Mosk); 1990 Apr; 68(4):96-9. PubMed ID: 2370792
    [No Abstract]   [Full Text] [Related]  

  • 2. Does perioperative high-dose prednisolone have clinical benefits for generalized myasthenia gravis?
    Sekine Y; Kawaguchi N; Hamada C; Sekiguchi H; Yasufuku K; Iyoda A; Shibuya K; Fujisawa T
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):908-13. PubMed ID: 16675232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Muscle contractility in chronic disorders of neuromuscular transmission].
    Gekht BM; Sanadze AG; Strokov IA
    Biull Eksp Biol Med; 1984 Jul; 98(7):28-31. PubMed ID: 6466822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with programmed steroid treatment with thymectomy in nonthymomatous myasthenia gravis.
    Endo S; Yamaguchi T; Saito N; Otani S; Hasegawa T; Sato Y; Sohara Y
    Ann Thorac Surg; 2004 May; 77(5):1745-50. PubMed ID: 15111178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of an acute pharmacologic test with prozerin on cardiac and central hemodynamic indices in patients with myasthenia].
    Orlov VA; Mamikonian AA; Nosakov SI; Gvindzhiliia TV
    Ter Arkh; 1989; 61(11):115-7. PubMed ID: 2633371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of the myasthenic reaction in various muscles of patients with myasthenia gravis.
    Ozdemir C; Schwab RS; Young RR
    Trans Am Neurol Assoc; 1970; 95():300-2. PubMed ID: 5514396
    [No Abstract]   [Full Text] [Related]  

  • 7. [Left ventricular systolic function in patients with myasthenia gravis].
    Cong ZQ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Apr; 21(2):103-6, 127-8. PubMed ID: 3208604
    [No Abstract]   [Full Text] [Related]  

  • 8. P-glycoprotein function in peripheral T lymphocyte subsets of myasthenia gravis patients: clinical implications and influence of glucocorticoid administration.
    Tanaka S; Masuda M; Nakajima K; Ido N; Ohtsuka T; Nishida M; Utsumi H; Hirano T
    Int Immunopharmacol; 2009 Mar; 9(3):284-90. PubMed ID: 19101657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On a study of hemodynamics in myasthenia].
    Gil'mar IS; Kravets VM; Puzhaĭlo VI
    Vrach Delo; 1967 Aug; 8():84-7. PubMed ID: 5612710
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical effects of pancreatic extracts on myasthenic patient].
    Takaoka Y; Takamori M; Ichinose M
    Shinkei Kenkyu No Shimpo; 1970; 14(3):453-7. PubMed ID: 5531594
    [No Abstract]   [Full Text] [Related]  

  • 11. [Electrocardiographic changes in myasthenia gravis].
    Lurie B; Kott E; Freud M
    Harefuah; 1969 Nov; 77(10):455-6. PubMed ID: 5397702
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiac involvement in myasthenia gravis.
    Ashok PP; Ahuja GK; Manchanda SC; Jalal S
    Acta Neurol Scand; 1983 Aug; 68(2):113-20. PubMed ID: 6637388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Massive prednisolone administration in myasthenia gravis--electrophysiological examination].
    Yanagizawa N; Shoji S; Tsukagoshi H; Toyokura Y
    Nihon Rinsho; 1973 Feb; 31(2):321-6. PubMed ID: 4737112
    [No Abstract]   [Full Text] [Related]  

  • 14. A cause of reversible dysphagia: an unusual presentation of myasthenia gravis.
    Brostoff JM; Dahdaleh D; Birns J
    Eur J Intern Med; 2008 Jan; 19(1):70. PubMed ID: 18206608
    [No Abstract]   [Full Text] [Related]  

  • 15. Multidrug resistance-1 (MDR-1) in autoimmune disorders IV. P-glycoprotein overfunction in lymphocytes from myasthenia gravis patients.
    Richaud-Patin Y; Vega-Boada F; Vidaller A; Llorente L
    Biomed Pharmacother; 2004 Jun; 58(5):320-4. PubMed ID: 15194168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrence of non-myasthenic symptoms with myasthenia gravis.
    Iseki K; Mezaki T; Kawamoto Y; Tomimoto H; Fukuyama H; Shibasaki H
    Neurol Sci; 2007 Apr; 28(2):114-5. PubMed ID: 17464478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Exacerbation of myasthenia gravis by pefloxacin].
    Vial T; Chauplannaz G; Brunel P; Leriche B; Evreux JC
    Rev Neurol (Paris); 1995 Apr; 151(4):286-7. PubMed ID: 7481384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of a negligible lesion of heart function in myasthenia gravis by noninvasive technics].
    Zhang TH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1987 Oct; 20(5):276-9. PubMed ID: 3450484
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dynamics of myocardial contractility and indicators of the central hemodynamics in patients with chronic renal failure treated by hemodialysis].
    Dzhavad-Zade MD; Aliev TA; Gel'fgat EB; Agaev MM; Usubova FN
    Ter Arkh; 1985; 57(12):77-80. PubMed ID: 4089772
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical manifestations of myasthenia gravis - review of cases seen at the Lagos University Teaching Hospital.
    Ojini FI; Danesi MA; Ogun SA
    Niger Postgrad Med J; 2004 Sep; 11(3):193-7. PubMed ID: 15505649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.